| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1aa877e508ad0f3a2ed38b5c6157f444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07dea5a44bbe138ae41ac0c1e341e9f3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e47263277a291c54e1dc41c46f959f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1df9e37bc7e1bb0054f2a026f21163fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70e6c1ff4f1297ac127edd811b46af2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07f44db4bcf0e939bc7788476ad154dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae6ddd006ae58417fb5f959e37f4fc9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_512c695423814aab53629475c84c1655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92f4b141c39177ca4d690cf0fe6d88cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a74bc266b7b14b00df332a92682c774 |
| publicationDate |
2011-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0711796-A2 |
| titleOfInvention |
human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity |
| abstract |
FUNCTION BLOCKING ANTIBODIES OF HUMAN AND HUMANIZED ANTI-ALPHA 5BETA INTEGRINS WITH REDUCED IMMUNOGENICITY. These are human or humanized recombinant polypeptides that bind to the Î ± 5β5 integrin with high affinity and blocking function. In addition, diagnostic and pharmaceutical applications of polypeptides are described. |
| priorityDate |
2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |